Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment

被引：4
|
作者：
Magge, Tara [1 ]
Shaikh, Hira [2 ]
Chaudhary, Rekha [2 ]
机构：
[1] Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45221 USA
[2] Univ Cincinnati, Dept Hematol & Oncol, Cincinnati, OH USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2022年 / 29卷 / 06期
关键词：
PHASE-III; CHEMOTHERAPY; SURVIVAL; INHIBITORS; NIVOLUMAB; RATES;
D O I：
10.1097/MJT.0000000000001186
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E767 / E769
页数：3
相关论文
共 50 条
  • [41] Metastatic malignant melanoma mimicking a salivary gland basaloid neoplasm after treatment with nivolumab
    Lajara, Sigfred
    Landau, Michael
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (09) : E370 - E373
  • [42] Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report
    Clark, Joseph, I
    Bufalino, Shams
    Singh, Shruti
    Borys, Ewa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [43] Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study
    Weichenthal, Michael
    Ellebaek, Eva
    Mangana, Joanna
    Asher, Nethanel
    Gavrilova, Iva
    Kandolf, Lidija
    Ugurel, Selma
    Hausschild, Axel
    Meier, Friedegund
    Leiter, Ulrike
    Livingstone, Elisabeth
    Gebhardt, Christoffer
    Gutzmer, Ralf
    Ruhlmann, Christina H.
    Mahncke-Guldbrandt, Louise
    Haslund, Charlotte A.
    Kopec, Sylwia
    Teterycz, Pawel
    Bender, Marc
    Poudroux, Wilfried
    Munoz-Couselo, Eva
    Berciano-Guerrero, Miguel-Angel
    Shalamanova, Gergana
    Depalo, Danielle K.
    Brozic, Jasmina Maric
    Chiarion-Sileni, Vanna
    Arance, Anna
    Ziogas, Dimitrios
    Robert, Caroline
    Velde, Anthonie Obik van de
    Gassama, Awa Aminata
    Shapira, Ronnie
    Benbetzalel, Guy
    Grynberg, Shirly
    Ramelyte, Egle
    Bertoldo, Fabio
    Delprete, Valerio
    Gaudy-Marqueste, Caroline
    Mohr, Peter
    Dummer, Reinhard
    Ascierto, Paolo A.
    Gogas, Helen
    Espinosa, Enrique
    Lebbe, Celeste
    Rutkowski, Piotr
    Haanen, John
    Schadendorf, Dirk
    Svane, Inge Marie
    EUROPEAN JOURNAL OF CANCER, 2025, 220
  • [44] Local therapy in advanced melanoma after immune checkpoint inhibitors aiming to achieve complete response
    de Barros e Silva, Milton Jose
    Teixeira, Marcos Rezende
    Lobo, Matheus de Melo
    Molina, Andre Sapata
    Bertolli, Eduardo
    Santos Filho, Ivan Dunshee de Abranches Oliveira
    Ribeiro, Heber Salvador Castro
    Pelizon, Antonio Cassio de Assis
    Pinto, Clovis Antonio Lopes
    Duprat Neto, Joo Pedreira
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1272 - 1278
  • [45] Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas
    Moinard-Butot, F.
    Oriel, M.
    Tricard, T.
    Cazzato, R. L.
    Pierard, L.
    Gaillard, V
    Werle, P.
    Lindner, V.
    Martin, S.
    Schuster, C.
    Roy, C.
    Burgy, M.
    Anthony, A.
    Bigot, C.
    Boudier, P.
    Fritsch, A.
    Olland, A.
    Malouf, G.
    Lang, H.
    Barthelemy, P.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [46] Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment
    Sustarsic, Elahu G.
    Junnila, Riia K.
    Kopchick, John J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 441 (01) : 144 - 150
  • [47] Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence
    Cybulska-Stopa, Bozena
    Rogala, Pawel
    Czarnecka, Anna M.
    Lugowska, Iwona
    Teterycz, Pawel
    Galus, Lukasz
    Rajczykowski, Marcin
    Dawidowska, Anna
    Piejko, Karolina
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    ADVANCES IN MEDICAL SCIENCES, 2020, 65 (02): : 316 - 323
  • [48] Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
    Besser, Michal J.
    Shapira-Frommer, Ronnie
    Itzhaki, Orit
    Treves, Avraham J.
    Zippel, Douglas B.
    Levy, Daphna
    Kubi, Adva
    Shoshani, Noa
    Zikich, Dragoslav
    Ohayon, Yaara
    Ohayon, Daniel
    Shalmon, Bruria
    Markel, Gal
    Yerushalmi, Ronit
    Apter, Sara
    Ben-Nun, Alon
    Ben-Ami, Eytan
    Shimoni, Avichai
    Nagler, Arnon
    Schachter, Jacob
    CLINICAL CANCER RESEARCH, 2013, 19 (17) : 4792 - 4800
  • [49] Complete response to perioperative treatment using nivolumab for metastatic renal cell carcinoma: A case report
    Ikarashi, Daiki
    Nakamura, Yasuyuki
    Shimodate, Hitoshi
    Usui, Yoshitaka
    Ujiie, Takashi
    Ohara, Wataru
    UROLOGY CASE REPORTS, 2019, 24
  • [50] Contribution of "complete response to treatment" to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis
    Bulut, Gulcan
    Oytun, Merve Guner
    Almuradova, Elvina
    Harman, Mustafa
    Uslu, Ruchan
    Karabulut, Bulent
    PLOS ONE, 2021, 16 (11):
12345